<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04046354</url>
  </required_header>
  <id_info>
    <org_study_id>KY2018001</org_study_id>
    <nct_id>NCT04046354</nct_id>
  </id_info>
  <brief_title>Microwave vs. Radiofrequency Ablation for Benign Thyroid Nodules: A Multicenter Randomized Controlled Trial Study</brief_title>
  <official_title>Clinical Trial of Microwave Ablation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compared with traditional treatment methods, ultrasound-guided thermal ablation is more
      targeted, less invasive and more reliable. The study compared microwave ablation and
      radiofrequency ablation to evaluate the efficacy and safety in the treatment of benign
      thyroid nodules with a multicenter data, which will provide a basis for clinical treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ultrasound-guided minimally invasive treatment has accurate positioning, higher targeting, no
      need for general anesthesia, less trauma for patients, and more reliable efficacy.Currently,
      it mainly includes percutaneous anhydrous ethanol injection, radiofrequency ablation and
      microwave ablation for the treatment of thyroid nodules.Currently, radiofrequency ablation
      and microwave ablation are mainly used to treat thyroid nodules.

      This study was a randomized, parallel, positive control, and non-inferiority multicenter
      clinical study.Radiofrequency ablation was used as the positive control.Follow-up was
      conducted at 1, 3, 6 and 12 months after ablation. The primary endpoint was the rate of
      nodule volume reduction at 12 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 30, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Volume reduction rate of thyroid nodules</measure>
    <time_frame>up to 12 months.</time_frame>
    <description>volume reduction rate，VRR=(Volume before treatment - volume at follow-up)/Volume before treatment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Benign Thyroid Nodules</condition>
  <condition>Ablation</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The group will use microwave ablation equipment to treat benign thyroid nodules.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group will use radiofrequency ablation equipment to treat benign thyroid nodules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound-guided Percutaneous Microwave Ablation</intervention_name>
    <description>Ultrasound-guided Percutaneous Microwave Ablation</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound-guided Percutaneous Radiofrequency Ablation</intervention_name>
    <description>Ultrasound-guided Percutaneous Radiofrequency Ablation</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 years and ≤75 years

          -  The pathological diagnosis was benign thyroid nodules within 6 months

          -  Diameter ≥2cm, solid &gt; 80%, the number of multiple nodules≤ 3

          -  Participate voluntarily and sign the informed consent

        Exclusion Criteria:

          -  Coagulation mechanism disorder or bleeding tendency

          -  Patients with severe cardiopulmonary insufficiency

          -  Blood pressure cannot be effectively controlled

          -  abnormal liver function

          -  Blood glucose cannot be effectively controlled

          -  Abnormal thyroid function

          -  Allergic history of ultrasound contrast agent

          -  Suspicious lymph node metastasis in the cervical region

          -  Abnormal contralateral vocal cord function

          -  Pregnant and lactating women

          -  Have participated in clinical trials of any drug and/or medical device within 3 months
             prior to enrollment

          -  The researchers believe that there are any other factors that are not suitable for
             inclusion or that affect participants' participation in the study.

          -  Patients with inner pacemaker, hearing aid, metal stent, titanium clip, internal
             (external) steel plate and other metal objects.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jie Yu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Yu, Doctor</last_name>
    <phone>8610-66939530</phone>
    <email>jiemi301@163.com</email>
  </overall_contact>
  <reference>
    <citation>Rastogi A, Bhadada SK, Bhansali A. Nodular goiter with multiple cystic and solid swellings. Indian J Endocrinol Metab. 2012 Jul;16(4):651-3. doi: 10.4103/2230-8210.98034.</citation>
    <PMID>22837936</PMID>
  </reference>
  <reference>
    <citation>Kihara M, Hirokawa M, Masuoka H, Yabuta T, Shindo H, Higashiyama T, Fukushima M, Yamada O, Takamura Y, Ito Y, Kobayashi K, Miya A, Miyauchi A. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases. Auris Nasus Larynx. 2013 Jun;40(3):308-11. doi: 10.1016/j.anl.2012.09.007. Epub 2012 Oct 24.</citation>
    <PMID>23103151</PMID>
  </reference>
  <reference>
    <citation>Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005 Jul;236(1):132-9.</citation>
    <PMID>15987969</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yu Jie</investigator_full_name>
    <investigator_title>Associate chief physician</investigator_title>
  </responsible_party>
  <keyword>microwave</keyword>
  <keyword>thyroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

